Xingkai Liu

900 total citations
39 papers, 692 citations indexed

About

Xingkai Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xingkai Liu has authored 39 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Xingkai Liu's work include Fibroblast Growth Factor Research (6 papers), Kruppel-like factors research (6 papers) and Epigenetics and DNA Methylation (6 papers). Xingkai Liu is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), Kruppel-like factors research (6 papers) and Epigenetics and DNA Methylation (6 papers). Xingkai Liu collaborates with scholars based in China, United States and Hong Kong. Xingkai Liu's co-authors include Lu Cai, Ping Zhang, Robert C.G. Martin, Xiaoye Fan, Yan Li, Tuo Wang, Jun Qi, Ping Zhang, Xueshibojie Liu and Guoyue Lv and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Xingkai Liu

39 papers receiving 690 citations

Peers

Xingkai Liu

EPIDE

ONCOL

IMMUN

Tae Woo Kim South Korea

Ajda Çoker Gürkan Türkiye

Chinenye Iwuji United Kingdom

Quangen Gao China

Junjie Hu China

Xuanfu Xu China

Masayoshi Fujisawa Japan

Su‐Yu Chien Taiwan

Ji Wook Moon South Korea

Tomoki Yagai United States

Tae Woo Kim South Korea

Xingkai Liu

477 ×1.3

179 ×1.1

EPIDE

107 ×0.9

ONCOL

159 ×1.6

80 ×1.1

IMMUN

Citations per year, relative to Xingkai Liu Xingkai Liu (= 1×) peers Tae Woo Kim

Countries citing papers authored by Xingkai Liu

Since Specialization

Citations

This map shows the geographic impact of Xingkai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingkai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingkai Liu more than expected).

Fields of papers citing papers by Xingkai Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingkai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingkai Liu. The network helps show where Xingkai Liu may publish in the future.

Co-authorship network of co-authors of Xingkai Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xingkai Liu. A scholar is included among the top collaborators of Xingkai Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingkai Liu. Xingkai Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Zengli, Zhongqi Fan, Kangshuai Li, et al.. (2024). Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut. 73(8). 1350–1363. 10 indexed citations

Zhou, Yang, Qun Luo, Fan‐Gang Zeng, et al.. (2024). Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers. Molecules. 29(11). 2623–2623. 4 indexed citations

Zeng, Fan‐Gang, Xingkai Liu, Yang Zhou, et al.. (2024). Strophanthidin Induces Apoptosis of Human Lung Adenocarcinoma Cells by Promoting TRAIL-DR5 Signaling. Molecules. 29(4). 877–877. 8 indexed citations

Liu, Xingkai, et al.. (2024). Sleeping <6.55 h per day was associated with a higher risk of low back pain in adults aged over 50 years: a Korean nationwide cross-sectional study. Frontiers in Public Health. 12. 1429495–1429495. 1 indexed citations

Liang, Ying, Hu Xu, Li Mao, et al.. (2024). Prediction of early bladder outcomes after spinal cord injury: The HALT score. CNS Neuroscience & Therapeutics. 30(2). e14628–e14628. 1 indexed citations

Liu, Xingkai, et al.. (2024). Integrating surface electromyography into physical therapy training with the support of STEM education. Frontiers in Neurology. 15. 1501619–1501619. 1 indexed citations

Han, Yan, Rui Xiang, Xin Li, et al.. (2024). Ribosomal modification protein rimK-like family member A activates betaine-homocysteine S-methyltransferase 1 to ameliorate hepatic steatosis. Signal Transduction and Targeted Therapy. 9(1). 214–214. 3 indexed citations

Zhu, Li, Hui Liu, Yang Dou, et al.. (2023). A Photoactivated Ru (II) Polypyridine Complex Induced Oncotic Necrosis of A549 Cells by Activating Oxidative Phosphorylation and Inhibiting DNA Synthesis as Revealed by Quantitative Proteomics. International Journal of Molecular Sciences. 24(9). 7756–7756. 5 indexed citations

Fang, Tiantian, Yao Zhao, Qun Luo, et al.. (2022). G-quadruplex inducer/stabilizer pyridostatin targets SUB1 to promote cytotoxicity of a transplatinum complex. Nucleic Acids Research. 50(6). 3070–3082. 14 indexed citations

10.

Qi, Luyu, Chao Tang, Xingkai Liu, et al.. (2022). Baicalin Targets HSP70/90 to Regulate PKR/PI3K/AKT/eNOS Signaling Pathways. Molecules. 27(4). 1432–1432. 9 indexed citations

11.

Ding, Lei, et al.. (2022). Intracellular Reduction-Responsive Molecular Targeted Nanomedicine for Hepatocellular Carcinoma Therapy. Frontiers in Pharmacology. 12. 809125–809125. 9 indexed citations

12.

Liu, Xingkai, Qian Chen, Xuming Ji, et al.. (2022). Astragaloside IV promotes pharmacological effect of Descurainia sophia seeds on isoproterenol-induced cardiomyopathy in rats by synergistically modulating the myosin motor. Frontiers in Pharmacology. 13. 939483–939483. 5 indexed citations

13.

Huang, Xu, Lei Ding, Xingkai Liu, et al.. (2021). Regulation of tumor microenvironment for pancreatic cancer therapy. Biomaterials. 270. 120680–120680. 43 indexed citations

14.

Zhang, Ping, Zhen Sun, Xin Liu, et al.. (2021). Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway. Chemico-Biological Interactions. 344. 109500–109500. 14 indexed citations

15.

Fan, Xiaoye, Wei Wei, Jingbo Huang, Xingkai Liu, & Xinxin Ci. (2020). Isoorientin Attenuates Cisplatin-Induced Nephrotoxicity Through the Inhibition of Oxidative Stress and Apoptosis via Activating the SIRT1/SIRT6/Nrf-2 Pathway. Frontiers in Pharmacology. 11. 264–264. 51 indexed citations

16.

Liu, Xingkai, Dawei Sun, Guangyi Wang, et al.. (2019). Hem-o-lok clip found in the common bile duct 3 years after laparoscopic cholecystectomy and surgical exploration. Journal of International Medical Research. 47(2). 1052–1058. 5 indexed citations

17.

Yang, Huahong, Yun Gao, Xiaoye Fan, et al.. (2019). Oridonin Sensitizes Cisplatin-Induced Apoptosis via AMPK/Akt/mTOR-Dependent Autophagosome Accumulation in A549 Cells. Frontiers in Oncology. 9. 769–769. 52 indexed citations

18.

Cui, Guozhen, Robert C.G. Martin, Xingkai Liu, et al.. (2018). Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer. Nutrition & Metabolism. 15(1). 71–71. 8 indexed citations

19.

Liu, Xingkai, Tuo Wang, Xueshibojie Liu, et al.. (2016). Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation. International Immunopharmacology. 38. 324–331. 94 indexed citations

20.

Zhang, Quan, Yan Li, Tingting Liang, et al.. (2015). ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice. International Journal of Biological Sciences. 11(5). 559–568. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact